The pathological characteristics of T2D are complicated, including pancreas β-cells damage, decreased insulin sensitivity in target organs, inflammation, gut microbiota dysbiosis and immune disorders [2], and these are also potential therapeutic targets for T2D. This evidence concerns the gene INS and immune system disorder.